The use of carboxylic acid compounds to reduce or treat developmental disorders, including fragile X-chromosome syndrome, Angelman syndrome or Leiter syndrome

摘要

The present invention relates to a use of a carbamate compound represented by chemical formula 1, or a pharmaceutically acceptable salt, a solvate or a hydrate thereof for reducing or treating developmental disorders including fragile X syndrome, Angelman syndrome or Rett syndrome.